What will shape the Alzheimer’s disease conversation at #EAN2026? In 10 days, the congress begins. We’ll be following discussion around early diagnosis and the role of biomarkers. What topics are you most interested in? Tell us in the comments! #TimeIsNowAD

At #ADI2026, Lilly engages in the scientific dialogue on the evolving global challenge of Alzheimer’s disease care - reaffirming our commitment to advancing early diagnosis and supporting people living with dementia. #TimeIsNowAD #EarlyDiagnosis #AlzheimersAwareness

Early action matters in Alzheimer’s disease.¹,² At #ADI2026, the community discusses the importance of reducing delays in diagnosis and care. Share your perspective in the comments! #TimeIsNowAD #EarlyDiagnosis #AlzheimersAwareness

2 weeks until the #ADI2026 Global Conference kicks off. Researchers, clinicians, advocates, and people living with dementia will exchange perspectives on the future of Alzheimer’s disease care. Which topics do you hope to see highlighted? Tell us in the comments! #TimeIsNowAD

Thank you to everyone who contributed to #ADPD2026! The conversations once more underscored how collaboration across disciplines moves Alzheimer’s disease research and care forward. Lilly is proud to have supported this event as a Platinum Plus sponsor. See you next year! #AlzheimersAwareness #TimeIsNowAD

Today is the start of #ADPD2026! We are live in Copenhagen and excited to connect with the community as we explore new insights on mechanisms, prevention, and care in Alzheimer’s disease. What discussions are you looking forward to? Follow us for updates! #AlzheimersAwareness #TimeIsNowAD

Stigma and lack of awareness are barriers for timely detection.¹ At the 35th Alzheimer Europe Conference in Bologna, we ask: how can we reduce stigma and promote timely support? #35AEC #TimeIsNowAD

Only 5 days to go until the 35ᵗʰ Alzheimer Europe Conference in Bologna! Lilly, as a gold sponsor, is proud to be part of this important discussion on advancing Alzheimer’s disease care, policy, and research. See you there! #35AEC #TimeIsNowAD #AlzheimersAwareness

Dr. Juan Fortea highlights how innovations in biomarkers can support timely and accurate diagnosis of Alzheimer’s disease. Yet, many barriers within the healthcare system still limit patient access to these tools.¹⁻⁴ How can we change this? #AlzheimersAwareness #WorldAlzheimersMonth #TimeIsNowAD

Prof. Alberto Benussi discusses the critical challenge of timely Alzheimer’s disease detection, when symptoms are subtle and often overlooked.¹,² How could timely detection be improved in your healthcare setting? #WorldAlzheimersMonth #TimeIsNowAD

Watch Dr. Alma Ghirelli share her vision for timely Alzheimer’s disease detection, driven by structured screening programs, accessible diagnostic tools, and stronger #AlzheimersAwareness.¹⁻³ Could this be the key to timely diagnosis? #WorldAlzheimersMonth #TimeIsNowAD

60% of specialists say stigma and lack of awareness delay patients seeking help for early signs of Alzheimer’s disease.¹ At Lilly, we believe #TimeIsNowAD to tackle barriers to timely diagnosis and improved care support. Join the conversation during #WorldAlzheimersMonth.